September 18, 2020: The Week in Cancer News
The AACR issues an extensive report on cancer disparities, and more news of the week from Cancer Today.
Progress Against Cancer
The AACR issues an extensive report on cancer disparities, and more news of the week from Cancer Today.
Racial disparities in incidence and mortality exist for many cancers, prompting researchers to explore social and biological factors that could be responsible. John Carpten, PhD, of the University of Southern California’s Keck School of...
Patients with bladder cancer who are treated with an immunotherapeutic may face worse outcomes if they also take proton pump inhibitors.
The inaugural Cancer Disparities Progress Report, published today by the American Association for Cancer Research (AACR), highlights the urgent need to reduce cancer health disparities and achieve health equity for all people, regardless of race,...
Doctors and researchers point out that instructions on scalp cooling were not formulated with Black patients in mind, and cancer news of the week from the staff of Cancer Today magazine.
A trial of the targeted therapy osimertinib for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
<!-- wp:paragraph --> <p>Personal use of permanent hair dye is generally not associated with increased cancer risk, and more news of the week from <em>Cancer Today</em> magazine.</p> <!-- /wp:paragraph -->
Research published in March 2020 found the use of an antioxidant supplement was associated with an increased risk of cancer recurrence or death.
The European Society for Medical Oncology (ESMO) issued guidance on genetic sequencing metastatic cancer patients and other news of the week selected by the staff of Cancer Today magazine.
Virtual scientific meetings have become the “new normal” in the COVID-19 era, enabling researchers to present and discuss recent advances in their respective fields, facilitating potential collaborations and conversations, and ultimately allowing science to continue to move forward.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More